Go to home page.

2026

Watanabe T, Yoshinami D, Yamasaki H, Tanaka Y, Ohtsuka M, Taniguchi T. DGCR8 regulates multiple processes of transcription coupled nucleotide excision repair. Sci Rep, 2026, 16:7112.

2025

Watanabe T, Taniguchi T. Semi-automated image acquisition and analyses for broad users utilizing macro keyboards. Microscopy, 2025, 74:437.

2024

Machitani M, Nomura A, Yamashita T, Yasukawa M, Ueki S, Fujita K, Ueno T, Yamashita A, Tanzawa Y, Watanabe M, Taniguchi T, Saitoh N, Kaneko S, Kato Y, Mano H, Masutomi K. Maintenance of R-loop structures by phosphorylated hTERT preserves genome integrity. Nat Cell Biol, 2024, 26:932.

2022

Kanao R, Kawai H, Taniguchi T, Takata M, Masutani C. RFWD3 and translesion DNA polymerases contribute to PCNA modification-dependent DNA damage tolerance. Life Sci Alliance, 2022, 5:e202201584.

2021

Suzuki R, Murata MM, Manguso N, Watanabe T, Mouakkad-Montoya L, Igari F, Rahman MM, Qu Y, Cui X, Giuliano AE, Takeda S, Tanaka H. The fragility of a structurally diverse duplication block triggers recurrent genomic amplification. Nucleic Acid Res, 2021, 43:2678.

2020

Tanaka H, Watanabe T. Mechanisms Underlying Recurrent Genomic Amplification in Human Cancers. Trends Cancer, 2020, 6:462.

2019

Taniguchi T. REV1-POL ζ Inhibition and Cancer Therapy. Mol Cell, 2019, 75:419.

Hu WF, Krieger KL, Lagundžin D, Li X, Cheung RS, Taniguchi T, Johnson KR, Bessho T, Monteiro ANA, Woods NT. CTDP1 Regulates Breast Cancer Survival and DNA Repair Through BRCT-specific Interactions With FANCI. Cell Death Discov, 2019, 5:105.

2018

Taniguchi T. REV1-POL ζ Inhibition and Cancer Therapy. Mol Cell, 2019, 75:419.